Primary Record
Ixazomib
- In stock
- 7,592 g
- Purity
- 99.4 %
- CAS
- 1072833-77-2
Compound Identifiers & Properties
- CAS
- 1072833-77-2
- PubChem CID
- 25183872
- SMILES
- B([C@H](CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O
- Canonical SMILES
- CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B(O)O
Names & Synonyms
- Ixazomib
- MLN2238
- 1072833-77-2
- ixazomibum
- Ixozamib
- NINLARO
- Ixazomib [INN]
- Ixazomib citrate
- Ixazomib Impurity
- MLN-2238
- Ixazomib (USAN)
- Ixazomib (MLN2238)
- Ixazomib (Standard)
- Ixazomib(MLN2238)
- Ixazomib [USAN:INN]
- Ixazomib Intermediates
- MLN 2238
- IXAZOMIB [USAN]
- MLN2238(Ixazomib)
- RefChem:56272
- C14H19BCl2N2O4
- IXAZOMIB [MI]
- MLN-9708 FREE BASE
- MFCD18251438
- D01MML
- IXAZOMIB [WHO-DD]
- Ixazomib (MLN-2238)
- CHEMBL2141296
- cc-437
- CHEBI:90942
- MLN9708
- DTXSID701025662
- GTPL8450
- Ixazomib, 98% - 1G 1g
- orb1306436
- SCHEMBL3742758
- SCHEMBL29353014
- CTK4A5116
- KS-00000PQX
- EX-A547
- L01XX50
- UNII-71050168A2
- (R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid
- DTXCID001509928
- GLXC-90359
- (R)-(1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)boronic acid
- AMY19380
- BCP02410
- BCP24078
- MLN 9708
- MLN-9708
- ABP000732
- BDBM50398609
- EBC-11463
- HY-10453R
- NSC766907
- s2180
- AKOS015995120
- ZINC169946773
- ACN-043692
- BCP9000953
- CCG-264938
- CS-1657
- DB09570
- FI65049
- NSC-766907
- RL00318
- 1072833-77-2 (free)
- NCGC00249611-01
- NCGC00249611-03
- NCGC00249611-04
- AC-28456
- AS-55976
- AT-42310
- BC659994
- BP-43659
- HY-10453
- SC-94531
- SY103733
- AB0033791
- 71050168A2
- A4008
- NS00073560
- SW219743-1
- X7547
- J3.602.191H
- A10600
- A25328
- D10130
- MLN2238,MLN 2238,MLN-2238/
- S-7673
- [(1R)-1-{2-[(2,5-dichlorophenyl)formamido]acetamido}-3-methylbutyl]boronic acid
- EN300-7360341
- [(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]boronic acid
- Boronic acid, b-((1R)-1-((2-((2,5-dichlorobenzoyl)amino)acetyl)amino)-3-methylbutyl)-
- BRD-K78659596-001-01-3
- BRD-K78659596-001-03-9
- Q20948663
- B0084-286487
- ((1R)-1-((2,5-DICHLOROBENZAMIDO)ACETAMIDO)-3-METHYLBUTYL)BORONIC ACID
- [(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methyl-butyl]boronic acid
- 1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid
- (R)-1-[2-(2,5-Dichlorobenzamido)acetamido]-3-methylbutylboronic Acid
- N-[(1R)-1-borono-3-methylbutyl]-N(2)-(2,5-dichlorobenzoyl)glycinamide
- ((1R)-1-((2-((2,5-dichlorobenzoyl)amino)acetyl)amino)-3-methylbutyl)boronic acid
- ((1R)-1-(2-((2,5-dichlorophenyl)formamido)acetamido)-3-methylbutyl)boronic acid
- (1R)-1-{2-[(2,5-dichlorophenyl)formamido]acetamido}-3-methylbutylboronic acid
- B-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]boronic acid
- N-[(1R)-1-(Dihydroxyboryl)-3-methylbutyl]-2-[(2,5-dichlorobenzoyl)amino]acetamide
- N2-(2,5-Dichlorobenzoyl)-N-[(1R)-1-(dihydroxyboryl)-3-methylbutyl]-glycinamide
- [(1~{r})-1-[2-[[2,5-Bis(Chloranyl)phenyl]carbonylamino]ethanoylamino]-3-Methyl-Butyl]boronic Acid
- Boronic acid, B-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-; B-[(1R)-1-[[2-[(2,5-Dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]boronic acid; Ixazomib; MLN 2238; Ninlaro
- MLN-2238|||[(1R)-1-[[2-[(2,5-Dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]boronic acid